Navigation Links
Infliximab scheduled treatment has proven to be an effective strategy in IBD patients
Date:10/25/2007

Crohn's disease (CD) and ulcerative colitis (UC) are chronic-relapsing diseases, the clinical courses of which are characterized by periods of remission and periods of acute flare up, determining clinical symptoms which have a strong impact on the quality of life for patients. For many years, corticosteroids have represented the cornerstone of therapy for induction of remission in Inflammatory Bowel Disease (IBD); however, the side-effects emerging with long-term use exceeded the clinical benefits. Recently, Infliximab (IFX) has become an alternative choice in the treatment strategies for CD and UC. Some safety issues are associated with IFX use, mostly related to the development of adverse events (e.g. opportunistic infections, autoimmune disorders and infusion reactions). Major concerns are related to the reactivation of latent tuberculosis and development of malignancy, even if there is no clear evidence the use of IFX increases the incidence of solid cancers. The research published on issue 39 of World Journal of Gastroenterology and led by Renato Caviglia at University Campus Biomedico in Italy aimed to retrospectively evaluate the safety and efficacy of long-term therapy with IFX, reviewing the medical charts of 41 IBD patients who received, after a loading dose of 3 IFX infusions, scheduled retreatment every 8 weeks as maintenance protocol.

Results of this retrospective study confirm current data on the efficacy of IFX in inducing a rapid clinical response in CD and UC, and support the finding, emerging from uncontrolled study data, of prolonged clinical efficacy in maintaining long-lasting remission beyond 1 year of treatment. The steroid-sparing effect of IFX was another important finding emerging from our study, which confirmed the efficacy of a scheduled treatment regimen in avoiding the well-known morbidity associated with long-term corticosteroid therapy. Interestingly, long-term IFX therapy in IBD has been demonstrated to potentially modi
'/>"/>

Contact: You-De Chang
y.d.chang@wjgnet.com
0086-108-538-1892
World Journal of Gastroenterology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Rescheduled: Aerial Mosquito Treatment for Philadelphia
2. First Keyhole Heart Valve Surgery Scheduled in Britain
3. Advances in Treatment of Cataracts
4. Recommendations for Treatment of Blood Pressue
5. Thyroid hormone treatment hastens recovery after cardiac surgery
6. Feeding channel created by malaria parasite - a new target for malaria treatments
7. Now umbilical cord helps in stroke treatment.
8. Now AIDS treatment comes dirt-cheap
9. Breast cancer treatment to be determined by gene test
10. Hemopurifier may revolutionise AIDS treatment
11. New drug helps boost cancer treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... May 05, 2015 NCPDP announced today ... Program. The program establishes a three-year commitment of strategic ... of 10 Elite Partners. “AmerisourceBergen has supported our multi-stakeholder ... of NCPDP, “and this is a wonderful continuation and ... We can trace AmerisourceBergen back to our very first ...
(Date:5/5/2015)... DC (PRWEB) May 05, 2015 ... Optimity) will present at the 24th ... at 1:15 p.m. MT in Scottsdale, AZ. WEDI, ... nation’s leading nonprofit authority on the use of ... exchange. Donald Graf, National Director of Telemedicine for ...
(Date:5/5/2015)... May 05, 2015 Viverae®, a ... Bard Inc., a leading multinational developer, manufacturer and ... fields of vascular, urology, oncology and surgical specialty ... Award. The Vanguard Award recognizes outstanding achievement ... programs among Viverae’s significant client base. , Viverae ...
(Date:5/5/2015)... Los Angeles, CA (PRWEB) May 05, 2015 ... to treat and actually prevent a variety of health ... Doc utilized this modern research to adopt clean eating ... preservatives and artificial dyes associated with over-consumption of fast ... eating diet plans easy to follow and report ...
(Date:5/5/2015)... TX (PRWEB) May 05, 2015 MAP ... programs and revenue cycle management for addiction treatment facilities, ... as Vice President of Business Development. Mr. Mooney, who ... addiction treatment field, will be responsible for developing new ... distribution of MAP’s core products and new initiatives. , ...
Breaking Medicine News(10 mins):Health News:AmerisourceBergen Joins NCPDP Elite Partner Program 2Health News:AmerisourceBergen Joins NCPDP Elite Partner Program 3Health News:Optimity Advisors’ Hiliary Critchley, Telemedicine Expert, to Speak at WEDI Conference May 20th in Scottsdale, AZ 2Health News:Viverae® Honors C. R. Bard, Inc. with 2015 Vanguard Award 2Health News:Diet Doc Introduces Diet Plans that Teach Patients how to Eat Clean by Getting Back to Basics and Exchanging Processed Foods for Clean, Nutritious Foods 2Health News:Diet Doc Introduces Diet Plans that Teach Patients how to Eat Clean by Getting Back to Basics and Exchanging Processed Foods for Clean, Nutritious Foods 3Health News:Jimmy Mooney, an Addiction Treatment Veteran, Named Vice President of Business Development at MAP Health Management, LLC 2
... proportions”, a study finding which says that hormone replacement therapy ... of heart disease. , The study published in ... replacement therapy or HRT, taken by women in their 50’s ... attacks and other such conditions. , This finding ...
... cancer patients in the U.S. fails to receive the ... study of hospital data from nine states found that ... Hispanic race, or insured by Medicaid, were at greatest ... oncologists, by surgeons who perform few ovarian cancer surgeries, ...
... land. But there too strident voices are being raised in ... to ensure availability of lower-cost copies of biotechnology drugs that ... year. ,Generics are now allowed only for traditional, ... for complex biological drugs such as hormones or antibodies used ...
... hospitals in Mumbai will soon start an integrated trauma ... and trauma care //to patients on way to a ... powerful American Association of Physicians of Indian Origin (AAPI), ... citizens to avail fully equipped ambulances within minutes of ...
... at the Johns Hopkins Urology Robotics Lab report the ... can safely power remote-controlled // robotic medical devices used ... imaging. The motor that drives the devices can be ... and more precise than a human hand. ,"Lots ...
... food industry is estimated to be worth over $200 million and ... Confederation of Indian Industry (CII). ,The growth of the ... the already booming food retail industry, which is currently growing at ... discussed in a two-day international food meet to be held in ...
Cached Medicine News:Health News:Hormone Replacement Therapy- Not A Fallen Angel 2Health News:Many Women Undertreated for Ovarian Cancer 2Health News:Law Emerging in US for Generic Versions of Biotech Medicine 2Health News:Law Emerging in US for Generic Versions of Biotech Medicine 3Health News:Integrated Trauma Care Facility in Mumbai 2Health News:Integrated Trauma Care Facility in Mumbai 3Health News:MRI Robotic Biopsies Simplified by PneuStep 2
(Date:5/5/2015)... LINCOLNSHIRE, Ill. , May 5, 2015 /PRNewswire/ ... medical diagnostic testing equipment and information systems technology, ... laboratory information systems company. This partnership allows Sysmex ... software and interfacing solution for physician offices and ... analyzer directly to Electronic Medical Record (EMR) systems. ...
(Date:5/5/2015)... 2015 GW Pharmaceuticals plc (Nasdaq: GWPH, ... company focused on discovering, developing and commercializing novel ... today the closing of the previously announced offering ... 1,600,000 American Depositary Shares (ADSs) at a price ... approximately $179.2 million (before deducting underwriting discount, commissions ...
(Date:5/5/2015)...  IBM Watson Health (NYSE: IBM ) today ... dozen leading cancer institutes to accelerate the ability of ... patients. The institutes will apply Watson,s ... minutes the ability to translate DNA insights, understand a ... literature to personalize treatment options. The project is part ...
Breaking Medicine Technology:Sysmex America, Inc. Partners with Medicus Middleware to Provide Physician Office Labs with Instrument Connectivity Directly to EMR 2Sysmex America, Inc. Partners with Medicus Middleware to Provide Physician Office Labs with Instrument Connectivity Directly to EMR 3GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 2GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 3GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 4Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 2Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 3Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 4Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 5Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 6
... 2011 The Food and Drug Administration,s international program ... on the new food safety law, as foreign companies ... learn how the law affects them. (Logo: ... became law in January, has been translated into 11 ...
... KALONA, Iowa, Sept. 29, 2011 ... has been installed at the Instituto Radioterapia del Este ... efficient workflow, the Protura system elevates the level of ... eliminates the need for many patients to travel for ...
Cached Medicine Technology:FDA CONSUMER HEALTH INFORMATION -- Foreign Exporters Study Food Safety Law 2CIVCO's Protura™ Installed at Puerto Rico's Instituto Radioterapia del Este 2CIVCO's Protura™ Installed at Puerto Rico's Instituto Radioterapia del Este 3
...
The Tew cranial/spinal retractor is designed for posterior fossa or intraspinal microsurgery where retraction is required. Clinical applications are: Posterior fossa microsurgery and intraspinal micr...
The Doro Halo retractor system is designed for all neurosurgical applications where retraction of the brain tissue and an armrest is required....
The Budde Halo brain retractor is designed for use in all intercranial procedures where retraction of delicate brain tissue is required....
Medicine Products: